482 related articles for article (PubMed ID: 12876092)
41. Publish or be damned? The fate of abstracts presented at the International Continence Society Meeting 2003.
Cartwright R; Khoo AK; Cardozo L
Neurourol Urodyn; 2007; 26(2):154-7. PubMed ID: 17252602
[TBL] [Abstract][Full Text] [Related]
42. The fate of abstracts submitted to a cancer meeting: factors which influence presentation and subsequent publication.
De Bellefeuille C; Morrison CA; Tannock IF
Ann Oncol; 1992 Mar; 3(3):187-91. PubMed ID: 1586615
[TBL] [Abstract][Full Text] [Related]
43. From abstract to publication: the fate of research presented at an annual forensic meeting.
Tambuscio S; Boghossian E; Sauvageau A
J Forensic Sci; 2010 Nov; 55(6):1494-8. PubMed ID: 20666914
[TBL] [Abstract][Full Text] [Related]
44. Evidence of publication bias in reporting acute stroke clinical trials.
Liebeskind DS; Kidwell CS; Sayre JW; Saver JL
Neurology; 2006 Sep; 67(6):973-9. PubMed ID: 17000963
[TBL] [Abstract][Full Text] [Related]
45. [The impact of the annual scientific meetings of the Israel Society of Rheumatology as measured by publication rates of the abstracts in peer-reviewed journals].
Perez S; Hashkes PJ; Uziel Y
Harefuah; 2004 Apr; 143(4):266-9, 319. PubMed ID: 15116582
[TBL] [Abstract][Full Text] [Related]
46. Time to full publication of studies of anticancer drugs for breast cancer, and the potential for publication bias.
Harris P; Takeda A; Loveman E; Hartwell D
Int J Technol Assess Health Care; 2010 Jan; 26(1):110-6. PubMed ID: 20059788
[TBL] [Abstract][Full Text] [Related]
47. Reporting quality and information consistency of randomized, controlled trials presented as abstracts at the American Urological Association annual meetings.
Turpen RM; Fesperman SF; Smith WA; Vieweg J; Dahm P
J Urol; 2010 Jul; 184(1):249-53. PubMed ID: 20483151
[TBL] [Abstract][Full Text] [Related]
48. Publication bias in blood and marrow transplantation.
Saeed M; Paulson K; Lambert P; Szwajcer D; Seftel M
Biol Blood Marrow Transplant; 2011 Jun; 17(6):930-4. PubMed ID: 21130176
[TBL] [Abstract][Full Text] [Related]
49. Peer review in publication: factors associated with the full-length publication of studies presented in abstract form at the annual meeting of the Society for Medical Decision Making.
Greenberg D; Wacht O; Pliskin JS
Med Decis Making; 2008; 28(6):938-42. PubMed ID: 19015283
[TBL] [Abstract][Full Text] [Related]
50. Publication outcome of abstracts presented at the AACC annual meeting.
Greene DN; Wilson AR; Bailey NM; Schmidt RL
Clin Chim Acta; 2016 May; 456():49-55. PubMed ID: 26926968
[TBL] [Abstract][Full Text] [Related]
51. Reporting quality of abstracts presented at the European Association of Urology meeting: a critical assessment.
De Sio M; Yakoubi R; De Nunzio C; Damiano R; Balsamo R; Di Palma C; Cantiello F; Azzarito G; Mirone V; Tubaro A; Autorino R
J Urol; 2012 Nov; 188(5):1883-6. PubMed ID: 22999688
[TBL] [Abstract][Full Text] [Related]
52. Does direction of results of abstracts submitted to scientific conferences on drug addiction predict full publication?
Vecchi S; Belleudi V; Amato L; Davoli M; Perucci CA
BMC Med Res Methodol; 2009 Apr; 9():23. PubMed ID: 19356245
[TBL] [Abstract][Full Text] [Related]
53. Media coverage of scientific meetings: too much, too soon?
Schwartz LM; Woloshin S; Baczek L
JAMA; 2002 Jun; 287(21):2859-63. PubMed ID: 12038934
[TBL] [Abstract][Full Text] [Related]
54. Time to publication of oncology trials and why some trials are never published.
Chapman PB; Liu NJ; Zhou Q; Iasonos A; Hanley S; Bosl GJ; Spriggs DR
PLoS One; 2017; 12(9):e0184025. PubMed ID: 28934243
[TBL] [Abstract][Full Text] [Related]
55. Rates of Discontinuation and Nonpublication of Head and Neck Cancer Randomized Clinical Trials.
Johnson AL; Fladie I; Anderson JM; Lewis DM; Mons BR; Vassar M
JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):176-182. PubMed ID: 31876933
[TBL] [Abstract][Full Text] [Related]
56. Do presenters to paediatric meetings get their work published?
Riordan FA
Arch Dis Child; 2000 Dec; 83(6):524-6. PubMed ID: 11087295
[TBL] [Abstract][Full Text] [Related]
57. Timely and complete publication of economic evaluations alongside randomized controlled trials.
Thorn JC; Noble SM; Hollingworth W
Pharmacoeconomics; 2013 Jan; 31(1):77-85. PubMed ID: 23329594
[TBL] [Abstract][Full Text] [Related]
58. Full-text publication of abstracts presented at meetings of a Latin American scientific society.
Dicembrino M; Anderson M; Vely AG; Ossorio MF; Ferrero F
Arch Argent Pediatr; 2014 Dec; 112(6):532-6. PubMed ID: 25362912
[TBL] [Abstract][Full Text] [Related]
59. Noncompletion and nonpublication of trials studying rare diseases: A cross-sectional analysis.
Rees CA; Pica N; Monuteaux MC; Bourgeois FT
PLoS Med; 2019 Nov; 16(11):e1002966. PubMed ID: 31751330
[TBL] [Abstract][Full Text] [Related]
60. Publication outcome for research presented at the Vascular Society of Great Britain and Ireland annual meetings.
Bhasin N; Scott DJ
Ann R Coll Surg Engl; 2007 Apr; 89(3):292-7. PubMed ID: 17431939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
